Pheon Therapeutics

About:

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Website: https://pheontx.com

Twitter/X: pheontx

Top Investors: Lightspeed Venture Partners, Perceptive Advisors, Biotechnology Value Fund, Atlas Venture, Forbion Capital Partners

Description:

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. The company was founded in 2022 and is based in London, England.